M. Hansen

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study

P. Castle, O. Vintermyr, M. Nygård, 2016, BMC Infectious Diseases.

Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework.

W. Quint, M. Arbyn, D. Ejegod, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Human papillomavirus prevalence and type distribution in urine samples from Norwegian women aged 17 and 21 years: A nationwide cross-sectional study of three non-vaccinated birth cohorts

R. Meisal, L. Trogstad, O. Ambur, 2016, Papillomavirus research.

An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway

E. Weiderpass, M. Nygård, E. Enerly, 2019, PloS one.

Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway

P. Magnus, L. Trogstad, O. Ambur, 2018, The Journal of infectious diseases.

HPV genotype distribution according to severity of cervical neoplasia.

A. Lie, M. Steinbakk, A. Eskild, 2010, Gynecologic oncology.